MedTrace Logo

The ANCA Vasculitis Questionnaire (AAV-PRO©)

NCT02507024 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 280

Last updated 2017-05-04

No results posted yet for this study

Summary

The aim of this project is to develop a disease specific patient reported outcome measure (PROM) for patients with AAV (the AAV-PRO). Investigators are developing and validating a questionnaire to assess quality of life in patients with ANCA-associated vasculitis (AAV). Patients with AAV have inflammation in the small blood vessels leading to involvement of a range of organs and can suffer from ongoing disease activity or treatment side effects. Quality of life can be measured by patient reported outcome measures (PROMs).

Conditions

  • Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss) (EGPA)
  • Churg-Strauss Syndrome (CSS)
  • Granulomatosis With Polyangiitis (Wegener's) (GPA)
  • Wegener Granulomatosis (WG)
  • Microscopic Polyangiitis (MPA)
  • ANCA-Associated Vasculitis (AAV)
  • Vasculitis

Interventions

OTHER

Online questionnaire

Sponsors & Collaborators

Principal Investigators

  • Joanna Robson, MD · University of Oxford

  • Peter A Merkel, MD, MPH · University of Pennsylvania

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02507024 on ClinicalTrials.gov